Inhibition of mouse hepatitis virus multiplication by phosphorothioate analogues of oligodeoxynucleotides complementary to the leader RNA

J Vet Med Sci. 1995 Dec;57(6):1081-3. doi: 10.1292/jvms.57.1081.

Abstract

Phosphorothioate oligodeoxynucleotides (PS-oligo) complementary to a leader RNA of mouse hepatitis virus (MHV) were more effective inhibitors of MHV multiplication than natural oligodeoxynucleotides (PO-oligo). Sequence-dependent inhibition of viral multiplication was shown at low concentrations (0.001-0.1 microM) of antisense PS-oligo. Phosphorothioate oligodeoxycytidine, PS-(dC)20 and PS-oligo, which has no significant homology to the MHV sequence, showed inhibitory effects on MHV multiplication at concentrations higher than 0.5 microM. These results showed that PS-oligo was more potent than PO-oligo in inhibition of MHV multiplication and that PS-oligo may inhibit MHV multiplication by two different mechanisms, that is, in sequence-dependent and -independent manners.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Base Sequence
  • Cell Line
  • Dose-Response Relationship, Drug
  • Mice
  • Molecular Sequence Data
  • Murine hepatitis virus / drug effects
  • Murine hepatitis virus / physiology*
  • Oligodeoxyribonucleotides / pharmacology
  • Oligonucleotides, Antisense / pharmacology*
  • RNA, Messenger*
  • Structure-Activity Relationship
  • Thionucleotides*
  • Virus Replication / drug effects*

Substances

  • Antiviral Agents
  • Oligodeoxyribonucleotides
  • Oligonucleotides, Antisense
  • RNA, Messenger
  • Thionucleotides